Catalyst Pharmaceuticals Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 182

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 3

Catalyst Pharmaceuticals General Information

Description

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Contact Information

Formerly Known As
Catalyst Pharmaceutical Partners
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 355 Alhambra Circle
  • Suite 801
  • Coral Gables, FL 33134
  • United States
+1 (305)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Former Stock Listing
CPRX
Corporate Office
  • 355 Alhambra Circle
  • Suite 801
  • Coral Gables, FL 33134
  • United States
+1 (305)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Catalyst Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Catalyst Pharmaceuticals‘s full profile, request access.

Request a free trial

Catalyst Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, d
Drug Discovery
Coral Gables, FL
182 As of 2026

San Diego, CA
 

Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Catalyst Pharmaceuticals Competitors (78)

One of Catalyst Pharmaceuticals’s 78 competitors is ACADIA Pharmaceuticals, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
Xeris Biopharma Holdings Formerly VC-backed Chicago, IL
Marinus Pharmaceuticals Private Equity-Backed Radnor, PA
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
Novartis Corporation Basel, Switzerland
You’re viewing 5 of 78 competitors. Get the full list »

Catalyst Pharmaceuticals Patents

Catalyst Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026035689-A1 Vamorolone solid oral dosage forms Pending 06-Aug-2024
EP-4387620-A1 Method for treating botulinum toxin poisoning Pending 19-Aug-2021
EP-4387620-A4 Method for treating botulinum toxin poisoning Pending 19-Aug-2021
US-20230074200-A1 Method for treating botulinum toxin poisoning Pending 19-Aug-2021
WO-2023023463-A1 Method for treating botulinum toxin poisoning Inactive 19-Aug-2021 A61K31/44
To view Catalyst Pharmaceuticals’s complete patent history, request access »

Catalyst Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Catalyst Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Catalyst Pharmaceuticals‘s full profile, request access.

Request a free trial

Catalyst Pharmaceuticals Investments & Acquisitions (3)

Catalyst Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Santhera Pharmaceuticals (Vamorolone License Located in Pratteln, Switzerland) for . The deal was made on 19-Jul-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Santhera Pharmaceuticals (Vamorolone License Located in Pratteln, Switzerland) 19-Jul-2023 Corporate Asset Purchase Buildings and Property
Santhera Pharmaceuticals Holding 20-Jun-2023 PIPE Biotechnology
FYCOMPA 24-Jan-2023 Merger/Acquisition Drug Discovery
To view Catalyst Pharmaceuticals’s complete investments and acquisitions history, request access »

Catalyst Pharmaceuticals Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
FYCOMPA

Catalyst Pharmaceuticals FAQs

  • When was Catalyst Pharmaceuticals founded?

    Catalyst Pharmaceuticals was founded in 2002.

  • Where is Catalyst Pharmaceuticals headquartered?

    Catalyst Pharmaceuticals is headquartered in Coral Gables, FL.

  • What is the size of Catalyst Pharmaceuticals?

    Catalyst Pharmaceuticals has 182 total employees.

  • What industry is Catalyst Pharmaceuticals in?

    Catalyst Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Catalyst Pharmaceuticals a private or public company?

    Catalyst Pharmaceuticals is a Private company.

  • What is the current valuation of Catalyst Pharmaceuticals?

    The current valuation of Catalyst Pharmaceuticals is .

  • What is Catalyst Pharmaceuticals’s current revenue?

    The current revenue for Catalyst Pharmaceuticals is .

  • How much funding has Catalyst Pharmaceuticals raised over time?

    Catalyst Pharmaceuticals has raised $222M.

  • Who are Catalyst Pharmaceuticals’s investors?

    New Leaf Venture has invested in Catalyst Pharmaceuticals.

  • Who are Catalyst Pharmaceuticals’s competitors?

    ACADIA Pharmaceuticals, Xeris Biopharma Holdings, Marinus Pharmaceuticals, BioMarin Pharmaceutical, and Novartis are some of the 78 competitors of Catalyst Pharmaceuticals.

  • When was Catalyst Pharmaceuticals acquired?

    Catalyst Pharmaceuticals was acquired on 16-Jul-2026.

  • Who acquired Catalyst Pharmaceuticals?

    Catalyst Pharmaceuticals was acquired by Angelini Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process